Marc TessierLavigne Net Worth - Insider Trades and Bio as of Jul 3, 2026

DNLIDenali Therapeutics Inc.SEC CIK: 0001437435

Estimated Net Worth

$121 Million

Last Updated: May 18, 2026 10:55 PM EST

Transaction Summary

Total Transactions72

Buy-Sell Ratio0.04

Buy Transactions1

Sell Transactions26

Transaction Volume

Total Volume-$67.73M

Net Volume$69.73M

Buy Volume$999.99K

Sell Volume-$68.73M

Trade Analysis

AVG Trade Size-$959.43K

Largest Trade$999.99K

Most Active MonthJun

Most Active Year2022

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Marc Tessier-Lavigne has an estimated net worth of $121 Million. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS, INC., PFIZER INC, AGIOS PHARMACEUTICALS INC, Denali Therapeutics Inc., Juno Therapeutics, Inc., and GENENTECH INC.

2021 was Marc Tessier-Lavigne's most active year for acquiring shares with 11 total transactions. Marc Tessier-Lavigne's most active month to acquire stocks was the month of December. 2021 was Marc Tessier-Lavigne's most active year for disposing of shares, totalling 42 transactions. Marc Tessier-Lavigne's most active month to dispose stocks was the month of August. 2022 saw Marc Tessier-Lavigne paying a total of $11,894,577.61 for 57,311 shares, this is the most they've acquired in one year. In 2020 Marc Tessier-Lavigne cashed out on 458,558 shares for a total of $24,611,206.99, their largest year based on trade value.

Holdings & Transactions

DNLIdenali therapeutics inc.

Updated: Jun 05, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	24.15K	—	—	Jun 05, 2025	2.14M	Grant	—	Jun 03	View
From 4	0.01	23.87K	—	—	Jun 04, 2024	2.14M	Grant	—	May 31	View
From 4	0.01	16.86K	—	—	Jun 05, 2023	2.12M	Grant	—	Jun 01	View
From 4	-0.01	20.00K	$30.48	-$609.60K	Nov 28, 2022	2.11M	Sale	Scheduled	Nov 23	View
From 4	-0.01	20.00K	$30.27	-$605.46K	Nov 03, 2022	2.13M	Sale	Scheduled	Nov 01 - 02	View
From 4	-0.01	20.00K	$30.82	-$616.30K	Sep 30, 2022	2.15M	Sale	Scheduled	Sep 28	View
From 4	-0.01	20.00K	$31.61	-$632.28K	Aug 25, 2022	2.17M	Sale	Scheduled	Aug 23	View
From 4	-0.01	20.00K	$35.61	-$712.11K	Jul 27, 2022	2.19M	Sale	—	Jul 25	View
From 4/A	-0.01	20.00K	$33.83	-$676.58K	Jun 28, 2022	2.26M	Sale	—	Mar 23	View
From 4	-0.03	60.00K	$30.72	-$1.84M	Jun 27, 2022	2.21M	Disposition	—	Jun 23 - 24	View
From 4	0.01	23.95K	—	—	Jun 06, 2022	2.29M	Grant	—	Jun 02	View
From 4	-0.01	20.00K	$33.83	-$676.58K	Mar 25, 2022	2.26M	Sale	—	Mar 23	View
From 4	-0.02	63.13K	$44.44	-$2.81M	Dec 30, 2021	2.48M	Sale	—	Oct 04 - 30	View
From 4	-0.04	94.38K	$44.53	-$4.87M	Jun 08, 2021	2.55M	Sale	Scheduled	Jun 07	View
From 4	0.00	8.30K	—	—	Jun 04, 2021	2.55M	Grant	—	Jun 02	View
From 4	-0.02	46.76K	$60.11	-$2.81M	May 24, 2021	2.54M	Sale	Scheduled	May 21 - 24	View
From 4	-0.00	3.24K	$60.11	-$194.59K	May 05, 2021	2.59M	Sale	Scheduled	May 03	View
From 4	-0.02	50.00K	$56.62	-$2.83M	Apr 05, 2021	2.59M	Sale	Scheduled	Apr 01	View
From 4	-0.04	100.00K	$66.22	-$6.62M	Mar 03, 2021	2.64M	Sale	Scheduled	Mar 01	View
From 4	-0.13	400.00K	$26.10	-$10.44M	Jun 18, 2020	2.74M	Sale	—	Jun 16	View
From 4	—	18.44K	—	—	Jun 05, 2020	18.44K	Grant	—	Jun 03	View
From 4	—	27.25K	—	—	May 31, 2019	27.25K	Grant	—	May 30	View
From 4	—	27.83K	—	—	Jun 15, 2018	27.83K	Grant	—	Jun 13	View
From 4	—	—	—	—	Dec 12, 2017	3.14M	Options	—	Dec 12	View
From 4	—	47.16K	—	—	Dec 08, 2017	47.17K	Grant	—	Dec 07	View
From 3	—	—	—	—	Dec 07, 2017	3.11M	—	—	—	View

REGNregeneron pharmaceuticals, inc.

Updated: Jan 05, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.92	2.09K	—	—	Jan 05, 2023	4.36K	Grant	—	Jan 03	View
From 4	0.92	2.09K	—	—	Jan 05, 2023	4.36K	Grant	—	Jan 03	View
From 4	-0.83	10.84K	$557.79	-$3.13M	Oct 03, 2022	2.27K	Sale	Scheduled	Sep 29 - 03	View
From 4	-0.77	7.44K	$535.48	-$2.30M	Mar 23, 2022	2.27K	Sale	Scheduled	Mar 21	View
From 4	-0.84	12.19K	$526.99	-$3.69M	Mar 18, 2022	2.27K	Sale	Scheduled	Mar 16 - 17	View
From 4	1.39	2.90K	—	—	Jan 05, 2022	4.98K	Grant	—	Jan 03	View
From 4	-0.65	3.78K	$518.20	-$1.11M	Dec 10, 2021	2.08K	Sale	Scheduled	Dec 09	View
From 4	-0.86	12.75K	$457.69	-$4.69M	Sep 15, 2021	2.08K	Sale	Scheduled	Sep 13	View
From 4	2.11	3.86K	—	—	Jan 05, 2021	5.69K	Grant	—	Jan 04	View
From 4	-0.89	15.00K	$370.90	-$5.79M	May 08, 2020	1.83K	Sale	—	May 06	View
From 4	-0.89	14.28K	$226.55	-$4.95M	Feb 14, 2020	1.83K	Sale	—	Feb 13	View
From 4	3.10	4.68K	—	—	Jan 06, 2020	6.19K	Grant	—	Jan 02	View
From 4	3.46	4.11K	—	—	Jan 04, 2019	5.29K	Grant	—	Jan 02	View
From 4	—	7.44K	—	—	Jan 03, 2018	7.44K	Grant	—	Jan 02	View
From 4	—	7.83K	—	—	Jan 05, 2017	7.83K	Grant	—	Jan 03	View
From 4	—	9.21K	—	—	Jan 06, 2016	9.21K	Grant	—	Jan 04	View
From 4	-0.45	5.00K	$323.69	-$2.67M	Aug 05, 2015	6.19K	Sale	—	Aug 05	View
From 4	-0.22	3.00K	$236.43	-$1.11M	Feb 27, 2015	10.47K	Sale	—	Feb 26	View
From 4	—	10.84K	—	—	Jan 05, 2015	10.84K	Grant	—	Jan 02	View
From 4	-0.19	3.20K	$201.54	-$903.58K	Aug 27, 2014	13.47K	Sale	—	Aug 26 - 27	View
From 4	—	12.75K	—	—	Jan 06, 2014	12.75K	Grant	—	Jan 02	View
From 4	-0.33	13.33K	$157.07	-$2.77M	May 08, 2013	26.67K	Sale	—	May 06	View
From 4	—	15.00K	—	—	Jan 03, 2013	15.00K	Grant	—	Jan 02	View
From 4	—	15.00K	—	—	Jan 04, 2012	15.00K	Grant	—	Jan 03	View
From 4	—	25.00K	—	—	Nov 22, 2011	25.00K	Grant	—	Nov 18	View
From 3	—	—	—	—	Nov 22, 2011	—	—	—	—	View

AGIOagios pharmaceuticals inc

Updated: Jun 23, 2016VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.21	8.50K	—	—	Jun 23, 2016	48.88K	Grant	—	Jun 21	View
From 4	0.39	11.26K	—	—	Jun 25, 2015	40.38K	Grant	—	Jun 23	View
From 4	0.93	14.00K	—	—	Jun 05, 2014	29.11K	Grant	—	May 30	View
From 4	1.22	55.55K	$18.00	$999.99K	Apr 03, 2014	101.01K	Purchase	—	Jul 24	View
From 4	2.46	10.75K	—	—	Dec 06, 2013	15.11K	Grant	—	Dec 04	View
From 3	—	—	—	—	Jul 23, 2013	45.45K	—	—	—	View

juno therapeutics, inc.

Updated: Jun 21, 2016

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	12.00K	—	—	Jun 21, 2016	12.00K	Grant	—	Jun 17	View
From 4	—	12.00K	—	—	Jun 16, 2015	12.00K	Grant	—	Jun 12	View
From 4	—	—	—	—	Dec 23, 2014	250.00K	Options	—	Dec 23	View
From 3	—	—	—	—	Dec 18, 2014	75.00K	—	—	—	View

PFEpfizer inc

Updated: Apr 24, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.19	4.60K	$35.36	$162.50K	Apr 24, 2015	29.10K	Grant	—	Apr 23	View
From 4	0.29	5.29K	$30.71	$162.50K	Apr 28, 2014	23.67K	Grant	—	Apr 24	View
From 4	0.34	4.54K	$30.26	$137.50K	Apr 26, 2013	17.79K	Grant	—	Apr 25	View
From 4	0.88	5.96K	$23.06	$137.50K	Apr 27, 2012	12.78K	Grant	—	Apr 26	View
From 3/A	—	—	—	—	Dec 29, 2011	104.00	—	—	—	View
From 4	—	6.74K	—	—	Dec 13, 2011	6.74K	Grant	—	Dec 12	View
From 3	—	—	—	—	Dec 13, 2011	—	—	—	—	View

genentech inc

EVP, RESEARCH DRUG DISCOVERY Officer

Updated: Mar 30, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	265.78K	$95.00	-$110.10K	Mar 30, 2009	—	Disposition	—	Mar 26	View
From 4	-0.73	18.75K	$66.57	-$500.06K	Jul 18, 2008	6.78K	Sale	—	Jul 16	View
From 3	—	—	—	—	Jun 13, 2008	1.16K	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions